Parallel Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.9K Buy
665
+120
+22% +$10.6K ﹤0.01% 1875
2025
Q4
$43.8K Hold
545
﹤0.01% 1910
2025
Q3
$53.2K Hold
545
﹤0.01% 1759
2025
Q2
$38K Buy
545
+307
+129% +$17.5K ﹤0.01% 1877
2025
Q1
$11.8K Sell
238
-50
-17% -$3.16K ﹤0.01% 2370
2024
Q4
$20.1K Buy
288
+145
+101% +$12K ﹤0.01% 2144
2024
Q3
$15K Sell
143
-75
-34% -$8.77K ﹤0.01% 2237
2024
Q2
$31K Sell
218
-205
-48% -$23.6K ﹤0.01% 1757
2024
Q1
$47.2K Buy
423
+400
+1,739% +$47.7K ﹤0.01% 1526
2023
Q4
$2.98K Sell
23
-45
-66% -$6.2K ﹤0.01% 2676
2023
Q3
$11.1K Buy
68
+45
+196% +$7.92K ﹤0.01% 2143
2023
Q2
$4.22K Hold
23
﹤0.01% 2490
2023
Q1
$3.06K Hold
23
﹤0.01% 2602
2022
Q4
$1.82K Hold
23
﹤0.01% 2716
2022
Q3
$1K Buy
+23
New +$1.49K ﹤0.01% 2829
2022
Q2
Sell
-2
Closed 2944
2022
Q1
$0 Sell
2
-6
-75% -$410 ﹤0.01% 2928
2021
Q4
$1K Buy
+8
New +$474 ﹤0.01% 2809
2018
Q3
Sell
-56
Closed -$1K 2215
2018
Q2
$1K Hold
56
﹤0.01% 1938
2018
Q1
$1K Hold
56
﹤0.01% 1942
2017
Q4
$2K Hold
56
﹤0.01% 1810
2017
Q3
$2K Hold
56
﹤0.01% 1807
2017
Q2
$1K Buy
+56
New +$1.18K ﹤0.01% 1955

Other funds holding ACLS

Parallel Advisors's ACLS Position: Q1 2026 in Review

Parallel Advisors increased its Axcelis (ACLS) stake by 22% in Q1 2026, buying an estimated $10.6K and bringing the position to 665 shares worth $61.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

Parallel Advisors first reported a position in ACLS in Q2 2017 and has held it in 22 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Parallel Advisors held 665 shares of Axcelis worth $61.9K as of Q1 2026.
  • Parallel Advisors bought 120 Axcelis shares in Q1 2026, an estimated $10.6K.
  • Axcelis made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1875 holding.
  • Parallel Advisors first reported a position in Axcelis in Q2 2017 and has held it in 22 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.